You just read:

Mezzion Pharma announces positive results from the Fontan Udenafil Exercise Longitudinal (FUEL) Trial, in adolescents with single ventricle heart disease who have undergone the Fontan procedure

News provided by

Mezzion Pharma Co. Ltd.

Jul 30, 2019, 19:42 ET